Safety Study for the Treatment of Abdominal Aortic Aneurysms

Inclusion Criteria: * Patient is 18 years of age or older * Patient has a AAA that meets one of the following criteria: 1. Aneurysm diameter of greater than 4.5 cm, or less than 4.5 cm with rapid expansion 2. The aneurysm has a saccular configuration where potential for rupture is increased or has exhibited dissection with potential for rupture at, or compromised flow to, vital structures * The vessels immediately proximal and distal to the lesion are capable of accommodating the study device * The access artery diameter and profile of the artery are capable of study device delivery. * Patient has proximal and distal neck lengths of greater than or equal to 1.0 cm * Patient is willing and able to comply with the follow-up regime. * Patient has provided written informed consent. Exclusion Criteria: * Patient has an aortic diameter greater than 36 mm. * Patients with ASA score less than 3 and deemed low risk by the Investigator for open surgical repair. * Patient has an indispensable inferior mesenteric artery. * Patient has a distal landing zone of \< 2 cm in length or \> 16 mm in diameter * Patient has iliac arteries whose tortuosity prevents passage of the introducer catheter. * If female, patient is pregnant * Patient has a life expectancy less than two years. * Patient has an allergy to any of the study device materials * Patient has coagulopathy or bleeding disorders * Patient for whom contrast medium or anticoagulation drugs are contraindicated * Patient has an uncontained rupture of the aneurysm. * Patient has an active systemic or localized groin infection * Patient has a connective tissue disease. * Patient has a GFR \< 30 ml/min/1.73m2 * Patient has a circumferential mural thrombus at the implantation site. * Patient is a candidate for a bifurcated endovascular graft. * Patient has an aortic trunk with an angle greater than 90°.